Research Funding Board

Ongoing

A-T Children’s Project – Research Grant Program

• Due: LOI submission rolling
• Funding: Up to $75,000 per year
• Project period: 1 to 2 years
• Purpose: To support translational and clinical research grants for research related to ataxia-telangiectasia including disease-modifying strategies that would prevent, slow, or stop the progression of the disease, symptom-improving strategies that address neural circuit function, immune system health and lung function, especially the neurological symptoms. (Grant decisions made and communicated 90 days after submission.)
• Eligibility: Investigators at all levels eligible to apply. Early career scientists are particularly encouraged to apply.

Alexander von Humboldt Research Foundation – Humboldt Research Fellowship

• Due: Rolling (selection committee meets: Feb/Mar, June/July, Oct/Nov)
• Funding: €3,170 monthly; €2,670 monthly (postdoctoral)
• Project period: 6 – 18 months; 6 – 24 months (postdoctoral)
• Purpose: To support research by scientists at any stage of their career in collaboration with a host at a German research institution of choice. Further financial support may be available. Allow 4 months for the review process.
• Eligibility: Eligible candidates must be postdoctorals (within 6 months of completing terminal degree to those who have completed their degree within the last 4 years), and established scientists who have completed their terminal degree within the last 12 years. November will be the final review cycle for 2022.

Allen Institute for AI – Allen AI Young Investigators

• Due: Rolling
• Funding: $100,000
• Project period:  1 to 3 years
• Purpose: To support postdocs in gaining research experience by providing opportunities to work collaboratively on AI2 projects while pursuing independent research agendas.
• Eligibility: Candidates should be withing 1 year of completing their PhD, or already have a PhD.

Alzheimer’s Association – Alzheimer’s Association Funding Program for Global Real-World Data Platforms (ALZ_RWD)

• Due: Rolling
• Funding: $100,000 to $1M
• Project period:  1 to 2 years
• Purpose: To support acceleration of global initiatives focused on developing, expanding and aligning RWD platforms’ infrastructure, data and impact with Alzheimer’s Network for Treatment and Diagnostics ALZ-NET (ALZ-NET), which seeks to connect clinical data from Alzheimer’s patients to the network of medical professional and researchers to encourage robust information sharing and education.
• Eligibility: A PI candidate must be a full-time faculty member or full-time paid employee of the organization submitting a proposal. See other eligibility requirements.

Alzheimer’s Association – Alzheimer’s Association World Wide FINGERS Network Funding Program (ALZ WW-FNFP)

• Due: Open
• Funding:Up to $1M
• Project period:  Up to 3 years
• Purpose: To provide startup funding and/or opportunities for ongoing studies to initiate WW-FINGERS (Worldwide Finnish Geriatric Intervention Study to Prevent Cognitive Impairment and Disability) like studies, to expand these studies or to add unique opportunities that enhance the study through global collaboration of data sharing to facilitate rapid knowledge dissemination and implementation.
• Eligibility: Open to U.S. and international researchers with proposals that focus on program objectives.

Alzheimer’s Association – Bridge Funding for Disrupted Neurodegenerative Research Grant Program (BFDN)

• Due: Rolling
• Funding: Not specified
• Project period:  Up to 3 to 12 months
• Purpose: To support early career researchers who have not yet had the opportunity to fully establish their labs and acquire ongoing funding, and to provide bridge or interim funding for salary and other direct costs for research projects focused on Alzheimer’s disease, Frontotemporal Dementia, Parkinson’s disease, Dementia with Lewy Bodies, atypical Parkinson’s and/or other related disorders that have been impacted by NIH changes.
• Eligibility: An applicant must be an Early Stage Investigator (ESI), defined as a Program Director/Principal Investigator who has completed their terminal research degree or post-graduate clinical training, whichever is later, within the past 10 years and has not previously competed successfully as a PD/PI for a substantial NIH independent research award (see NIH early career definition for more details). This grant is intended for ESI applicants who can demonstrate disruption in either their K or R or other ESI specific investigator-led award in recent months due to U.S. federal funding challenges and must provide the NIH review and/or summary. Applicants must be able to demonstrate financial need for their continued research program to move forward.

Angelman Syndrome Foundation – Angelman Syndrome Research Proposals Call for Proposals

• Due: Rolling; submission deadlines for subsequent review ocurring on August 15
• Funding: Up to $100,000 per year
• Project period:  1 to 2 years
• Purpose: To support research projects that address areas of unmet need in Angelman Syndrome research. Priority areas to include studying or correcting the heterozygous effect on non-UBE3A genes in deletion. See other priority areas.
• Eligibility: Researchers at all levels are eligible.

Boehringer Ingelheim U.S. – Investigator-InitiatedStudies(IIS)

• Due: Open
• Funding: Not Specified
• Project period:  Not Specified
• Purpose: To support proof of concept or exploratory studies and interventional and non-interventional and health outcomes research studies proposals. Priority Areas (proposals outside of priority areas will also be evaluated): Cardio-Renal-metabolic, Mental Health, Dermatology.
• Eligibility: Intended for U.S. based researchers.

Brutten Family Foundation – Grants

• Due: Open
• Funding: Not Specified
• Project period:  Not Specified
• Purpose: To fund projects that address an urgent need and have a clear strategy and goal towards supporting the well being of communities.
• Eligibility: Proposals with a clear goal, strategy, and timeline that align with BFF’s main pillars (the environment, education, and mental health) may be submitted. 501(c)(3) status required.

Childhood Arthritis and Rheumatology Research Alliance – Data Analysis Grant

• Due: Rolling submission
• Funding: Up to $10,000
• Project period:  Not specified
• Purpose: To support qualitative or quantitative data analyses on existing CARRA datasets from collaborative research projects. Funds may be requested to complete a specific set of tasks that will result in the timely publication of results.
• Eligibility: Researcher should have necessary data in hand at time of application submission.

Cystic Fibrosis Foundation – Path to a Cure: Pioneer Award

• Due: LOI submission rolling
• Funding: Negotiable
• Project period:  Not specified
• Purpose: To support development of treatments for the underlying cause of the disease and, ultimately, a cure for CF.
• Eligibility: Matching funding required. U.S.-based and non U.S.-based research and development focused companies welcome to apply. Milestone completion and subsequent funding requirement.

Conservation, Food & Health Foundation – Conservation, Food & Health Foundation Grants

• Due: January 1 (Round 1); July 1 (Round 2) annually
• Funding: $25,000-$50,000
• Project period: 1 to 2 years
• Purpose: To support projects that have the potential to advance the field, build capacity in local areas, promote replication, influence public opinion and policy, affect systems change, and benefit people beyond the scope of the immediate project (projects focused on underfunded issues and geographic areas preferred).
• Eligibility: Non-governmental local, state, and regional organizations in Africa, Asia, the Caribbean, Latin America, and the Middle East in the countries where the projects are base and organizations from upper-income countries working with local partners in these areas.

Cystic Fibrosis Foundation – Student Loan Repayment Program

• Due: During and up to 4 months after active award period
• Funding: $14,000 per year maximum
• Project period: One-time payment
• Purpose: To assist with repayment of educational loan debt associated with a graduate-level degree.
• Eligibility: Applicants must be current awardees of one of the following CFF programs: 1. First through fifth Year Clinical Fellows, 2. Harry Shwachman CF Clinical Investigator, 3. LeRoy Matthews Physician-Scientist, 4. Envision CF: Emerging Leaders in CF Endocrinology II Program, and 5. Developing Innovative Gastroenterology Specialty Training (DIGEST) Program. Other eligibility requirements may apply.

Department of Defense (DOD) – Air Force Research Laboratory (AFRL) – Neuroscience

• Due: Rolling
• Funding: Stipend (amount not specified)
• Project period: 1 year
• Purpose: To support mentored training of postdoctoral scientists who will gain hands-on experience and develop skills in molecular neuroscience research. Project focus: comparing how secondary insults after traumatic brain injury worsen cognition and motor activity, and increase damage to lungs, gut, and kidney. Program administered by Oak Ridge Associated Universities (ORAU).
• Eligibility: PhD received within 5 years of award date and 2-4 years of neuroscience research using quantitative neuropathology and immunohistochemistry required.

Diamond Blackfan Anemia Foundation – Research Grant

• Due: Rolling
• Funding: Not specified
• Project period: Not specified
• Purpose: To support projects that help investigators develop a clearer understanding of all aspects of Diamond Blackfan Anemia (DBA) pathophysiology.
• Eligibility: Postdoctoral fellows and researchers who have prior principal investigator (PI) experience may apply.

FamilieSCN2A Foundation – Hodgkin-Huxley Research Grant

• Due: Rolling (LOI)
• Funding: Not specified
• Project period: Not specified
• Purpose: To support projects that address fundamental gaps in the basic and translational science of SRDs and to accelerate therapy development to clinical trials in the SCN2A field.
• Eligibility: Established research scientists at accredited universities worldwide are eligible to apply.

Foundation for Anesthesia Education and Research (FAER) – Mentored Research Training Grants

• Due: February 15 and August 15 annually
• Funding: $250,000
• Project period: 2 years
• Purpose: To support the skills development of anesthesiologists and collection of preliminary data needed to be successful in obtaining future grants and publishing research as they seek to become independent investigators.
• Eligibility: Faculty members who have completed their core anesthesiology training within the past 10 years who are focused on any area of research that will contribute to advancement in patient care and has the potential to lead to extramural research (including basic science, clinical, translational, health services and education research.

Foundation for Anesthesia Education and Research (FAER) – Research Training Grants

• Due: February 15 and August 15 annually
• Funding: $75,000
• Project period: 1 year
• Purpose: To support training of anesthesiology residents in research techniques and scientific methods. Research areas: Basic science, clinical, translational, health services or education research.
• Eligibility: Anesthesiology trainees after CA-1 year; 80% protected time required.

Foundation for Anesthesia Education and Research (FAER) – Transition to Independence Grant

• Due: Rolling
• Funding: $75,000
• Project period: 1 year
• Purpose: To support the transition of scientists from mentored training-focused support to research independence for all types of cancers.
• Eligibility: Funds are awarded to institutions. Applicants must demonstrate that their project aligns with GFCR’s mission. 20% protected time required.

Foundation for Peripheral Neuropathy – Peripheral Neuropathy Research

• Due: Rolling LOI submission
• Funding: Not specified
• Project period: Not specified
• Purpose: To new investigators seeking to conduct research on regeneration and recovery related to peripheral nerves, encourage well-established researchers in other areas to utilize their knowledge and skills to peripheral neuropathy research, and to enable researchers with novel ideas to test and develop pilot data for seeking larger awards from NIH and other funding entities.
• Eligibility: New investigators, established investigators new to peripheral neuropathy research, and researchers with novel ideas relevant to the topic may apply.

Gateway for Cancer Research – GFCR Grant Program

• Due: Rolling
• Funding: $200,000 to $1.5 M
• Project period: 2 to 5 years
• Purpose: To fund early phase clinical trials at renowned institutions for all types of cancers.
• Eligibility: Funds are awarded to institutions. Applicants must demonstrate that their project aligns with GFCR’s mission.
• Note: Rolling LOI submissions aggregated 4 times a year. Submit LOI prior to deadline for this cycle.

Gateway for Cancer Research – SIO Integrative Program

• Due: Rolling
• Funding: $200,000 to $1.5 M
• Project period: 2 to 5 years
• Purpose: To fund integrative oncology research that pairs conventional therapies with evidence-based integrative therapies to manage symptoms and side effects from treatment and increase quality of life, especially post-treatment.
• Eligibility: Applicants must demonstrate that their project aligns with GFCR’s mission.
• Note: Rolling LOI submissions aggregated 4 times a year. Submit LOI prior to deadline for this cycle.

Gateway for Cancer Research – NCI/SPORE Program

• Due: Rolling
• Funding: $200,000 to $800,000
• Project period: 2 to 5 years
• Purpose: A partnership with the NCI to give SPORE recipients a chance to apply for supplemental funding for their early phase, innovative clinical trials and enable principal investigators and their respective institutions to start a new trial through an additional arm, add patient cohorts and/or new correlative analysis.
• Eligibility: Applicants must demonstrate that their project aligns with GFCR’s mission.
• Note: Rolling LOI submissions aggregated 4 times a year. Submit LOI prior to deadline for this cycle.

Hearst Foundations – Funding Priorities in Health

• Due: Rolling
• Funding: $100,000 minimum
• Project period: Not specified
• Purpose: To support healthcare programs focused on a number of different issues including improving access to high-quality healthcare for low-income populations and/or veterans, offering comprehensive healthcare to elderly populations, scaling innovative healthcare delivery systems to provide efficient, coordinated care, and research, particularly for early career investigators and/or efforts to find new cures for prevalent diseases like cancer.
• Eligibility: U.S.-based early career researchers may apply. Funding also supports U.S.-based regional hospitals, medical centers and specialized medical institutions providing access to healthcare for high-need populations. Professional development proposals will also be considered.

Immune Tolerance Network – Request for Applications

• Due: Open; Concept Proposals accepted year-round
  • Full applications accepted by invitation
• Funding: Not specified
• Project period: Not specified
• Purpose: To fund research in 1) allergy & asthma, 2) autoimmune diseases, 3) kidney & liver transplantation, and 4) assays & biomarkers.
• Note: ITN does not accept proposals for non-human or preclinical studies.

Lennox-Gastaut Syndrome (LGS) Foundation – Cure LGS 365 Research Grants

• Due: Open
• Funding: $25,000 (Level 1); $50,000 (level 2); $70,000 (level 3)
• Project period: Not specified
• Purpose: To provide seed funding for new basic, translational, and clinical research projects related to LGS, characterized by seizure types and hallmark EEG features. Priority areas include sleep, expressive communication, and EEG network evolution to LGS.
• Eligibility: Physicians and scientists holding a faculty or investigator appointment at any career level may apply.

Malan Syndrome Foundation – Research Grant Program

• Due: Rolling
• Funding: $30,000 per year
• Project period: 1 to 2 years
• Purpose: To support basic, translational, and clinical research that aims to advance the current understanding of Malan syndrome and identify disease-modifying treatments.
• Eligibility: Applicants must have a PhD, MD or equivalent and hold a full-time position as a researcher at any level (postdoctoral, staff scientist, assistant/associate/full professor) at an established academic or research institution, or pharmaceutical or biotechnology company. The proposed research must align with one of the high-priority research areas: 1) Creating novel disease models that replicate the human phenotype; increased understanding of the mechanisms regulating NFIX gene expression; 2) Identification of druggable targets that can increase NFIX expression and rescue haploinsufficient phenotype; 3) Identification of molecular pathophysiology associated with Malan syndrome in the central nervous system, and in cardiovascular, orthopedic, neuro-ophthalmologic, gastrointestinal and other pertinent areas that can inform translational research for drug discovery.

Michael J. Fox Foundation – Parkinson’s Disease Therapeutics Pipeline Program

• Due: Rolling pre-application
  • Full applications accepted by invitation
• Funding: Not specified
• Project period: Not specified
• Purpose: To advance therapeutic development through pre-clinical and/or clinical testing of approaches addressing unmet needs of people with Parkinson’s disease, to prevent, stop, or delay disease progression or reduce the burden of daily symptoms. Applicants with selected pre-proposals will be invited to submit an application.
• Eligibility: Open to industry and industry-academia collaborations.

NIH/FIC/NCI – International Research Scientist Development Award (IRSDA) (K01) Independent Clinical Trial Not Allowed

• Due: Standard March dates.
• Funding: Up to $150,000 per year
• Project period: Up to 5 years
• Purpose: To provide protected time for conducting postdoctoral mentored global health research in low-  and middle-income countries to strengthen global health research.

NIH – Administrative Supplements to Promote Research Continuity and Retention of NIH Mentored Career Development (K) Award Recipients and Scholars

• Due: Varies by awarding IC
• Funding: Up to $50,000 direct costs
• Project period: Up to 1 year
• Purpose: To sustain mentored investigator’s research during critical life events. Applications may be submitted in advance of a known event or after the fact.
• Note: Funds can be used for staff, supplies, or equipment within the original scope of research for the currently-funded grant period.

NIH – Notice of Special Interest (NOSI): Administrative Supplement for Continuity of Biomedical and Behavioral Research Among First-Time Recipients of NIH Research Project Grant Awards

• Due: Varies by awarding IC
• Funding: Up to $50,000 direct costs
• Project period: Up to 1 year
• Purpose: To enhance the retention of investigators facing critical life events who are approaching the first renewal of their first independent grant or to a second new NIH grant.

NIH – Notice of Special Interest: NCI Supports Applications for the Mentored Research Scientist Development Awards (K01) Within the Mission of the Division of Cancer Control and Population

• Due: Rolling through May 7, 2029
• Funding: Not specified
• Project period: Up to 5 years
• Purpose: To support early career scientists conducting research within the mission of the Division of Cancer control and Population Sciences for the Mentored Research Scientist Development Award (K01), with the goal of eliminating cancer and its consequences for those impacted. Standard submission dates apply: Cycle 1- Feb 12; Cycle 2 – June 12; Cycle 3 – October 12.
• Eligibility: Candidates must have a research or health-professional doctoral degree and be a U.S. citizen, permanent resident, or a non-citizen national of the U.S. Mentor required. This opportunity may also support individuals who will be training in a new field or who have had a hiatus in their research career due to illness or pressing family circumstances.

National Institutes of Health – Career Development (K) Awards

• New Applications due: annually on June 12, October 12
• Renewal/Revision/Resubmission: annually on March 12, July 12, November 12

National Institutes of Health – Individual Fellowship (F) Awards

National Institutes of Health – NIH Small Grant Program (R03)

Pediatric Dermatology Research Alliance (PeDRA) – Study Support Grants

• Due: Rolling
• Funding: Up to $4,000
• Project Period: 6 months.
• Purpose: To fund statistical and/or publication support of active PeDRA Studies
• Eligibility: Study Support Grants are available to PeDRA Members only.  Please login or join PeDRA to access deadline details and other content.

Pediatric Brain Tumor Foundation – Pediatric Brain Tumor Research Funding Proposals

• Due: Rolling
• Funding: Not specified
• Project Period: 1 to 3 years
• Purpose: To provide seed funding for exploring novel concepts of rising stars in research as they pursue advancements and novel treatments for children with brain tumors and larger government-funded grants.
• Eligibility: Applicants must be early career scientists and/or clinicians studying any pediatric brain tumor type or subtype.

Rare Diseases Clinical Research Network – Congenital and Perinatal Infections Consortium Scholars Program

• Due: Rolling
• Funding: Not specified
• Project period: 2 years
• Purpose: Sponsored by the Career Enhancement Core of the Congenital and Perinatal Infections Consortium (CPIC) to support scholars conducting mentored research.
• Eligibility: Applicants must be fellows or early-stage faculty.

Rare Diseases Clinical Research Network – Pichichero Family Foundation Research Award in Pediatric Infectious Diseases Request for Proposals

• Due: Rolling
• Funding: $50,000
• Project period: Up to 2 years
• Purpose: To support outstanding investigators performing translational or clinical research focused on pediatric infectious diseases, with priority given to research involving vaccine development or that expands field knowledge of pathogenesis and moves the field towards the development of new vaccines and therapeutics.
• Eligibility: Applicants must be members of PIDS. Intended for Pediatric infectious diseases physicians and scientists with MDs and/or PhDs. Established investigators whose pursuing a new direction in research may also apply.

Rare Diseases Clinical Research Network – VCRC-VF Fellowship Program

• Due: Rolling
• Funding: Not specified.
• Project period: 2 years
• Purpose: Sponsored by the Vasculitis Clinical Research Consortium (VCRC) to provide mentored training for physician-investigators who show commitment to vasculitis and seek to pursue specialized training involving clinical and/or translational patient-oriented clinical investigation. Fellowships will begin in alignment with the academic calendar in North America (alternate schedules may be accepted).
• Eligibility: Applicants must have an MD, PhD, or equivalent and have completed residency and preferably have sub-specialty training relevant to vasculitis. A training license or full license to practice in the state/province where the fellowship will take place and host country citizenship or valid visa is required.

Robert Wood Johnson Foundation – Pioneering Ideas: Exploring the Future to Build a Culture of Health

• Due: Open
• Funding: Not specified
• Project period: Up to 3 years
• Purpose: To support research that addresses any four areas of focus: Future of Evidence; Future of Social Interaction; Future of Food; Future of Work, and also research that offers novel approaches to advancing health equity and progress towards a Culture of Health.
• Eligibility: Lead applicants must be based in the U.S. if there are international collaborations. Preference will be given to applicants that are either public entities or nonprofit organization with tax-exempt status.

The Milbank Foundation – Grants

• Due: Open (LOIs required)
• Funding: Not specified
• Project period: Not specified
• Purpose: To support projects that seek to integrate people living with disabilities into all aspects of American life. Priorities include: rehabilitation and re-integration of veterans, especially veterans with disabilities, helping seniors to age where they choose through non-institutional, community-based health and social services, market-oriented, patient-centered health care reforms across the country, and mental health programs, substance abuse and suicide prevention, especially around young people.
• Eligibility: U.S.-based, tax-exempt organizations (under the U.S. IRS code) are eligible.

Tourette Association of America – Support for Research Consortia and Collaborative Research Projects

• Due: Rolling (LOI)
• Funding: Not specified
• Project period: Not specified
• Purpose: To provide seed funding to research consortia working on large issues relevant to TS, including the TAA genetics consortium, neuroimaging consortium, behavioral sciences consortium, deep brain stimulation registry and Treating Tourette Together summit and other projects that have direct impact on the patient and research community.
• Eligibility: Funding will be provided for projects involving collaboration among researchers and institutions.

W.K. Kellogg Foundation – Grants

• Due: Open (LOIs accepted at any time)
• Funding: Not specified
• Project period: Not specified
• Purpose: To support organizations creating a world where children, families and communities can thrive. One area of focus: Increasing accessibility to health care for mothers, birthing people and babies where they live.
• Eligibility: Organizations with projects that match the mission (advancing innovative, community-driven solutions) of W.K. Kellogg Foundation may apply.

May

Bristol Myers Squibb Foundation – Robert A. Winn Excellence in clinical Trials: Career Development Award (Winn CDA) 

• Due: May 4, 2026
• Funding: $120,000 per year
• Project Period: 2 years
• Purpose: To support the training of early career clinician scientists in designing and implementing clinical trials that engage more communities in research areas that include cancer, cardiovascular and cardio-metabolic disease, and neuropsychiatry.
• Eligibility: Applicants must be physician (MD, DO, or international equivalent), have an active U.S. medical license, and be in the first to eighth year of a full-time clinical faculty appointment. U.S. citizenship of Lawful Permanent Residence is required. Applicants must work under the guidance of an experienced mentor who is a clinical investigator.

Pfizer – Pfizer Independent Medical Education Grant RFP: Capacity Building for Clinical Trials in Sickle Cell Disease (SCD) – Education for Healthcare Professionals

• Due: May 5, 2026
• Funding: $50,000
• Project Period: 1 year
• Purpose: To strengthen clinical trial readiness for Sickle Cell Disease (SCD) by enhancing workforce education and building durable internal infrastructure to support high-quality clinical research in SCD.
• Eligibility: Medical, nursing, allied health, and/or pharmacy professional schools; healthcare institutions (both large and small); patient advocacy groups, professional organizations/medical societies; medical education companies; and other entities with a mission related to healthcare professional education and/or healthcare improvement may apply. The applicant must be the project/program lead or an authorized designee. The award will be given to the institution.

Pfizer – 2026-RD-US-CardiacAmyloidosis-Fellowship RFP

• Due: May 6, 2026
• Funding: Up to $80,000
• Project Period: 1 year
• Purpose: To support institutions with fellowship programs for Cardiologists or Heart Failure Advanced Practice Providers that have a strong focus on clinical practice, research, and education to further the understanding of ATTR cardiac amyloidosis and to promote the importance of training healthcare professionals to recognize, diagnose and manage the disease and conduct research in this area.
• Eligibility: Accredited, U.S.-based academic institutions, (in particular, institutions with clinical training programs in regions where there are continued workforce challenges and that have a strong focus on clinical practice, research, and education to further the understanding of ATTR cardiac amyloidosis) are eligible. All fellows who will be supported by this grant at an awarded institution must be a U.S. citizen, permanent resident, refugee, or asylee, or hold an appropriate non-immigrant visa status authorizing employment in the U.S.

Pfizer – Advances in Migraine Management

• Due: May 8, 2026
• Funding: Up to $200,000
• Project Period: 2 years
• Purpose: To support projects that identify and address the educational needs of healthcare professionals to improve the care, management, and outcomes of adult patients with migraine.
• Eligibility: U.S.-based medical, dental, nursing, allied health, and/or pharmacy professional schools, healthcare institutions, professional organizations/medical societies, medical education companies, and other entities with a mission related to healthcare professional education and/or healthcare improvement may apply. The PI must be an employee or contractor of the organization submitting the application. For projects offering continuing education credit, the requesting organization must be accredited.

Alzheimer’s Drug Discovery Foundation & Association for Frontotemporal Degeneration (AFTD) – Request for Proposals: Accelerating Drug Discovery for Frontotemporal Degeneration

• Due: May 11, 2026 (LOI)
• Funding: $300,000
• Project Period: 1 year
• Purpose: To support innovative small molecule and biologic (antibodies, oligonucleotides, peptides, gene therapy etc.) drug development programs for FTD.
• Eligibility: For China-, France-, Germany-, Italy-, Japan-, Korea-, Spain-, and U.S.- based initiatives by medical, professional schools; healthcare institutions (both large and small); professional organizations/medical societies; medical education companies; and other entities with a mission related to healthcare professional education and/or healthcare improvement. The applicant must be the project/program lead or an authorized designee of that individual (e.g., project/program lead’s grant coordinator). The requesting organization must be legally able to receive funding directly from Pfizer Inc.

Pfizer – Evidence Based Safety Contextualization of JAK inhibitors in the Treatment of Moderate-to-Severe Atopic Dermatitis

• Due: May 13, 2026
• Funding: Up to $75,000
• Project Period: Up to 1 year
• Purpose: To support projects that seek to educate providers on contextualization of the safety data for janus kinase inhibitors (JAKis) in the treatment of moderate-to-severe (M2S) atopic dermatitis (AD) based on the totality of the current literature.
• Eligibility: For China-, France-, Germany-, Italy-, Japan-, Korea-, Spain-, and U.S.- based initiatives by medical, professional schools; healthcare institutions (both large and small); professional organizations/medical societies; medical education companies; and other entities with a mission related to healthcare professional education and/or healthcare improvement. The applicant must be the project/program lead or an authorized designee of that individual (e.g., project/program lead’s grant coordinator). The requesting organization must be legally able to receive funding directly from Pfizer Inc.

Pfizer – Sickle Cell Advocacy & Leadership Empowerment (SCALE) Grants

• Due: May 13, 2026
• Funding: Not specified
• Project Period: Not specified
• Purpose: To support innovative approaches to some of the persistent challenges in access to care impacting those living with SCD, in the focus areas of Assessment and Analysis, Policy and Advocacy, or Data Collection/Surveillance.
• Eligibility: For U.S. initiatives. Grant application submissions must demonstrate alignment to at least one of the grant categories (connection of program elements to potential policy goals/change (short-term/long-term), quantifiable program impact and ability to measure results/outcomes, or capacity to deliver quality program(s) to achieve established goals, and plan for policy advocacy.

Schmidt Sciences – Schmidt Science Fellows Program

• Due: May 15, 2026
• Funding: Up to $75,000
• Project Period: 2 years
• Purpose: To provide exceptional scientists with a immersive and transformative opportunity to collaborate across disciplines, tackle global challenges, and accelerate their scientific leadership and impact.
• Eligibility: Applicants must have completed all requirements for conferral of their PhD (in natural sciences: astronomy, biology, chemistry, physics, and earth sciences, engineering, mathematics, computing (and relevant sub-disciplines) between May 15, 2025 and June 20, 2026. They must be nominated by their PhD institution (one of the nominating partner organizations). Applicants should have a clear record of academic achievement of the highest quality in the sciences, a record of continuous innovation and/or use of new technologies. PhDs in social sciences, MD-PhDs and veterinary PhDs are not eligible.

Pfizer – Pfizer Independent Medical Education Grant RFP: Evidence-Based Education on the Potential Impact of a Generic JAK Inhibitor on the Management of Rheumatologic Diseases

• Due: May 21, 2026
• Funding: Up to $100,000
• Project Period: Up to 1 year
• Purpose: To support medical education proposals focused on improving healthcare professionals’ understanding of the clinical impact, appropriate use, and evolving role of a generic JAK inhibitor in rheumatologic care.
• Eligibility: For U.S.-based Healthcare professionals involved in the diagnosis and long-term management of rheumatologic diseases, such as rheumatologists, primary care physicians, nurse practitioners, physician assistants, infusion/clinic nurses, pharmacists, specialty pharmacy clinicians, rheumatology fellows and trainees.

Neurocritical Care Society (NCS) – NCS Research Training Fellowship

• Due: May 26, 2026
• Funding: Up to $100,000
• Project Period: 1 year
• Purpose: To support individuals with high potential to become independent researchers in the field of neurocritical care in obtaining preliminary data necessary to apply for subsequent scientist development training grants to conduct clinical, translational, and outcomes research aimed at developing innovative and cost-effective interventions for acute neurological disorders.
• Eligibility: Applicants must be active NCS members within 5 years of completion of terminal degree or clinical training (physicians, advanced practitioners, nurses, pharmacists, PhD researchers, etc. at all levels) and be interested in becoming an independent researcher. 75% protected time, a mentor who is an established investigator with independent funding, and the applicant’s institutional/departmental chair’s support are required (including a written commitment to providing supplemental salary and research expenses funding).

PhRMA Foundation – Translational Medicine Faculty Starter Grants

• Due: May 27, 2026 (LOI)
• Funding: $100,000
• Project Period: 1 year
• Purpose: To support U.S.-based education projects to increase the awareness of healthcare professionals (HCPs) on the opportunities and challenges of applying artificial intelligence, integrated diagnostic & antifungal stewardship and clinical decision support tools to improve speed and precision of treatment selection and to enhance clinical management for patients with invasive mold infections (IMIs).
• Eligibility: Applicants must be full-time, promotion-eligible, research-intensive faculty (with faculty status that began after January 1, 2025 and a terminal degree conferred after January 1, 2017) at a PhD-granting accredited U.S. university by the time of LOI submission. Preference will be given to applicants with startup funding less than $750,000. Applicants with funding over $250,000 are ineligible. A minimum of three first author publications is required for eligibility.

June

American Cancer Society – Clinician Scientist Development Grant (CSDG)

• Due: June 1, 2026
• Funding: $135,000 per year
• Project Period: 3 to 5 years
• Purpose: To support full-time faculty (trained primarily as clinicians) seeking to establish themselves as independent clinician-scientists.
• Eligibility: Clinician trained, independent investigators who have a doctoral degree, an active clinical license, and who participate in clinical care may apply. Applicants must work at a U.S. academic institution or eligible non-profit. Applicants must not be a current or former PI of an individual mentored training grant or PI of an independent extramural research grant that is more than 1 year and more than $100,000, including multi-PI awards.

American Cancer Society – Mission Boost Grants (MBG)

• Due: June 1, 2026
• Funding: $66,000, $68,000, and $70,000 a year stipend
• Project Period: Up to 3 years
• Purpose: To support research projects that specifically focus on translation to human testing.
• Eligibility: Independent investigators at any career stage, with a full-time faculty appointment (or equivalent), who work at an academic institution in the U.S. or eligible nonprofit may apply.

American Cancer Society – Postdoctoral Fellowships

• Due: June 1, 2026
• Funding: $66,000, $68,000, and $70,000 a year stipend
• Project Period: Up to 3 years
• Purpose: To support new investigators in research training programs to position them for independent careers in cancer research.
• Eligibility: Applicants must be a U.S. citizen or a non-U.S. citizen with an appropriate visa or lawful immigration status at the time of application, and be in a postdoctoral position at a U.S. academic institution or eligible non-profit. Applicants must have received their terminal degree no more than three years prior to time of application.

American Cancer Society – Research Scholar Grants

• Due: June 1, 2026
• Funding: Up to $215,000 per year
• Project Period: Up to four years
• Purpose: To support investigator-initiated grant proposals that align with an American Cancer Society’s priority research area (Etiology, Obesity/Healthy Eating and Active Living (HEAL), Screening and Diagnosis, Treatment, and Survivorship.
• Eligibility: Applicants must have had their first appointment as an independent, full-time faculty less than 10 years ago and must work at a U.S. academic institution or eligible non-profit. At time of application, applicants can be PI on no more than 1 R01 or R01 equivalent grant (R01 equivalent grant is defined as an award that is more $100, 000 direct costs per year for more than three years).

Lung Cancer Research Foundation – OUCH-Int’l and LCRF Research Grant Program on the Effects of Air Pollution and Climate Change on Carcinogenesis and Lung Cancer

• Due: June 2, 2026
• Funding: Up to $200,000
• Project Period: 2 years
• Purpose: To support innovative projects that examine the impact of climate change and environmental pollution on lung cancer risk, diagnosis, treatment, and outcomes and identifies strategies to mitigate these effects.
• Eligibility: Investigators at any career level may apply but must be affiliated with a non-profit academic or research institution. Inquiry related to eligibility should be sent to LCRF grants office (see Inquiries section below) before submitting an application and at least a week before submission deadline.

Alex’s Lemonade Stand Foundation for Childhood Cancer – R Accelerated Award Grant

• Due: June 11, 2026
• Funding: $800,000
• Project Period: 4 years
• Purpose: To support an original project that is not currently being funded, one that is clearly focused on accelerating the discovery of more effective, less toxic therapies for childhood cancers. Proposed projects should address a testable hypothesis based on strong scientific rationale.
• Eligibility: Applicants must have an MD, PhD, or MD/PhD, DO, MBBS or equivalent, be within ten years of their first faculty appointment at the Assistant Professor level, and be a first-time PI or co-PI of a pediatric cancer research-focused NIH R01 award or equivalent independent award. Institutional support required. Applicant institutions must be based in the U.S. or Canada but U.S. citizenship is not required for the individuals who will lead the project.

Incyte – Ingenuity Award in GVHD™

• Due: June 12, 2026 (LOI)
• Funding: $135,000
• Project Period: 1 year
• Purpose: To support the graft-versus-host disease (GVHD) community by funding novel initiatives that address challenges faced by GVHD patients, caregivers, and healthcare providers.
• Eligibility: Invited applicants will be asked to complete a round two application form. U.S.-based non-profit 501(c)(3), patient, policy and caregiver organizations, Healthcare providers, junior faculty from healthcare organizations, individuals or other companies collaborating with these organizations and institutions may apply.

July

American Association of Obstetrics and Gynecologists Foundation – Research and Training Scholarship

• Due: July 1, 2026
• Funding: $150,000 per year
• Project Period: Up to 3 years
• Purpose: A joint effort (ABOG/AAOGF & the Foundation for SMFM/AOGF) to support basic or translational research, disease pathogenesis, clinical diagnostics, interventions and prevention, epidemiology, and health services research by a candidate of proven ability who demonstrates significant talent, novel thought, and evidence of dedication to an academic career in Obstetrics and Gynecology in the U.S. or Canada.
• Eligibility: Eligible applicants must hold an MD or DO, have completed or expect to complete residency training in obstetrics and gynecology in the U.S.or Canada, and be eligible for ABOG certification. Membership in the Society for Maternal-Fetal Medicine (SMFM) and 75% protected time are required. Grant awardees with more than two years of prior K-award training, current recipients of certain K12 awards, or prior/current R01 grant holders are not eligible. Collaborative efforts with other departments strongly encouraged.

Awards

May

Vilcek Foundation  – 2027 Vilcek Prizes for Creative Promise in Biomedical Science

• Due: May 4, 2026
• Prize: $50,000
• Purpose: To support young, immigrant biomedical scientists who demonstrate outstanding early achievement in their fields. The winner will receive an unrestricted cash award.
• Eligibility: Applicants must be born outside the U.S. to non-American parents (residing in the U.S for at least four years), be no older than 38 years old, be a full-time, tenure track faculty position, and be a biomedical scientist who has conducted creative, independent research in basic, applied, or translational biomedical science with at least one publication as corresponding author.

NOMIS & Science – Young Explorer Award

• Due: May 15, 2026
• Prize: $15,000
• Purpose: Granted annually to recognize outstanding research performed by the applicant as described in a 1,000-word essay. The Grand Prize Award winner is automatically eligible to submit a funding proposal to the NOMIS Foundation. Two Grand Prize winners will also receive a 5-year digital subscription to Science and have their winning essay published in Science.
• Eligibility: Applicants must be career scientists with an MD, PhD or MD/PhD received within the last 10 years, at the time of entry. For early career scientists based on work done within the past 3 years.

June

American Association for the Advancement of Science (AAAS) – AAAS David and Betty Hamburg Award for Science Diplomacy

• Due: June 30, 2026
• Prize: $10,000 
• Purpose: To recognize an individual or limited number of individuals working together in the scientific and engineering or foreign affairs communities who are making major contributions to furthering science diplomacy. The winner also receives complimentary registration for the AAAS Annual Meeting and reimbursement for travel and hotel expenses to attend, and worldwide promotion of their achievements through AAAS communication channels, and the opportunity to be featured in an interview in Science & Diplomacy. 
• Eligibility: Applicants in the scientific or foreign policy community who have contributed to the role of science cooperation in building stronger links between and among societies are eligible. Self-nominations accepted. 

American Association for the Advancement of Science (AAAS) – AAAS Newcomb Cleveland Prize

• Due: June 30, 2026
• Prize: 25,000 
• Purpose: To recognize the author or authors of an outstanding paper published in Science. Eligible papers may include original research data, theory, or synthesis, and broaden or improve basic knowledge or is a technical achievement with a wide impact.
• Eligibility: The paper must be a first-time publication of the author’s original research work. The paper must include original research data, theory, or synthesis; is a fundamental contribution to basic knowledge or is a technical achievement of far-reaching consequence; and is a first-time publication of the author’s own work. Self-nominations will not be accepted for this award.

July

Science & SciLifeLab – Patient Safety Prize

• Due: July 15, 2026
• Prize:$30,000 (grand prize winner), $10,000 (for each category winners)
• Purpose: To recognize one young scientist for outstanding life science research for which they earned a doctoral degree in the previous two years (the research must have been performed while the entrant was a graduate student). The grand prize-winning essay will be published in Science; essays from the each category winner will be published online.
• Eligibility: Applicants must have been awarded their doctoral degree in 2024 or 2025, and the subject of their thesis should match one of the preferred subject tracks (Cell and Molecular Biology; Genomics, Proteomics and Systems Biology approaches; Ecology and Environment; and Molecular Medicine).